The clinical trial of TSO, Trichuris suis ova or CNDO-201, will be a randomized, double-blind, placebo-controlled, multicenter study involving 250 Chrohn’s disease patents.
More Articles on Gastroenterology:
14 Top Symptoms Leading to Gastroenterology Outpatient Visits
Dr. Carol-Lee Collins Joins KRMC in Arizona
La Peer Health Systems Launches Barrett’s Esophagus Center of Excellence
Next Up in GI & Endoscopy
-
Jacksonville, Fla.-based Borland Groover opened a gastroenterology office Nov. 16 in St. Johns County, the Jacksonville Daily Record reported. The…
-
Nutrition and gastroenterology seem like a natural fit, but one Illinois GI group leader said few practices have put them…
-
CMS’ final 2027 outpatient and ASC payment rule gives centers a 2.3% update, and GI leaders said many endoscopy procedures…
Stay current with ASC Review.
Becker's ASC Review Newsletter is sent Monday–Saturday.